title: Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia.
authors.forename: Wing-Yan
authors.initials: WY
authors.lastname: Au
authors.forename: Charmaine
authors.initials: C
authors.lastname: Hon
authors.forename: Kin
authors.initials: K
authors.lastname: Yau
authors.forename: Wico W
authors.initials: WW
authors.lastname: Lai
authors.forename: Bonnie M
authors.initials: BM
authors.lastname: Fong
authors.forename: Sidney
authors.initials: S
authors.lastname: Tam
authors.forename: Yok-Lam
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001766:Blindness / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D010087:Oxides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide